Democrats’ “Better Deal” Policy Statement Proposes Significant Changes for Antitrust/Competition Enforcement Alert
FTC Requires Divestitures in Generic Pharmaceutical Markets Even Though the Target Had Exited the Markets Alert
Hedge Fund’s Settlement With FTC Highlights Limits To HSR Investment-Only Exemption Alert
Federal Trade Commission Reaches Record $1.2 Billion Proposed “Pay for Delay” Settlement with Cephalon and Injunctive Relief Restricting Future Similar Settlements of Patent Infringement Cases Alert
Weil Serves as Antitrust Counsel to Actavis in the Sale of its Branded Respiratory Portfolio to AstraZeneca Article
Weil Advises Staples in its $6.3 Billion Acquisition of Office Depot Article
The FTC’s Challenge to Verisk’s Acquisition of EagleView: Distinct Customers May Constitute a Distinct Relevant Market Article
Supreme Court of Canada Allows Challenged Merger to Proceed on Efficiency Grounds Article
FTC Increases HSR Act Filing Thresholds and Interlocking Directorate Thresholds Alert
DOJ Requires Upstream Divestiture in Tyson Foods’ Acquisition of Hillshire Article